| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $43.8M | +26.3% |
| SG&A Expense | $13.0M | +28.0% |
| Operating Income | -$56.8M | -26.7% |
| Income Tax | $0 | — |
| Net Income | -$54.4M | -23.8% |
| EPS (Basic) | -$2.39 | +6.6% |
| EPS (Diluted) | -$2.39 | +6.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.3M | +33.0% |
| Short-term Investments | $34.2M | -39.9% |
| Current Assets | $50.2M | -28.1% |
| Total Assets | $50.7M | -28.2% |
| Current Liabilities | $9.8M | +11.5% |
| Stockholders' Equity | $40.9M | -33.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.9M | -33.6% |
| Investing Cash Flow | $24.2M | +242.0% |
| Financing Cash Flow | $30.2M | +6899.8% |